Lifevantage EPS - Earnings per Share 2012-2026 | LFVN
Lifevantage eps - earnings per share from 2012 to 2026. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Lifevantage Annual EPS | |
|---|---|
| 2026 | $0.40 |
| 2025 | $0.75 |
| 2024 | $0.23 |
| 2023 | $0.20 |
| 2022 | $0.24 |
| 2021 | $0.90 |
| 2020 | $0.79 |
| 2019 | $0.50 |
| 2018 | $0.41 |
| 2017 | $0.11 |
| 2016 | $0.42 |
| 2015 | $0.50 |
| 2014 | $0.71 |
| 2013 | $0.42 |
| 2012 | $0.77 |
| Lifevantage Quarterly EPS | |
|---|---|
| 2026-06-30 | $0.10 |
| 2026-03-31 | $0.11 |
| 2025-12-31 | $0.02 |
| 2025-09-30 | $0.17 |
| 2025-06-30 | $0.16 |
| 2025-03-31 | $0.26 |
| 2024-12-31 | $0.19 |
| 2024-09-30 | $0.14 |
| 2024-06-30 | $0.10 |
| 2024-03-31 | $0.13 |
| 2023-12-31 | $-0.05 |
| 2023-09-30 | $0.05 |
| 2023-06-30 | $0.15 |
| 2023-03-31 | $0.08 |
| 2022-12-31 | $-0.08 |
| 2022-09-30 | $0.05 |
| 2022-06-30 | $-0.11 |
| 2022-03-31 | $0.09 |
| 2021-12-31 | $0.01 |
| 2021-09-30 | $0.25 |
| 2021-06-30 | $0.35 |
| 2021-03-31 | $0.12 |
| 2020-12-31 | $0.26 |
| 2020-09-30 | $0.17 |
| 2020-06-30 | $0.26 |
| 2020-03-31 | $0.11 |
| 2019-12-31 | $0.30 |
| 2019-09-30 | $0.12 |
| 2019-06-30 | $0.26 |
| 2019-03-31 | $0.12 |
| 2018-12-31 | $0.06 |
| 2018-09-30 | $0.06 |
| 2018-06-30 | $0.21 |
| 2018-03-31 | $0.12 |
| 2017-12-31 | $0.02 |
| 2017-09-30 | $0.06 |
| 2017-06-30 | $0.01 |
| 2017-03-31 | $0.00 |
| 2016-12-31 | $0.02 |
| 2016-09-30 | $0.08 |
| 2016-06-30 | $0.16 |
| 2016-03-31 | $0.07 |
| 2015-12-31 | $0.11 |
| 2015-09-30 | $0.08 |
| 2015-06-30 | $0.04 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $0.10 |
| 2014-09-30 | $0.32 |
| 2014-06-30 | $0.15 |
| 2014-03-31 | $0.14 |
| 2013-12-31 | $0.21 |
| 2013-09-30 | $0.21 |
| 2013-06-30 | $0.00 |
| 2013-03-31 | $0.21 |
| 2012-12-31 | $0.00 |
| 2012-09-30 | $0.21 |
| 2012-06-30 | $0.63 |
| 2012-03-31 | $-0.35 |
| 2011-12-31 | $0.35 |
| 2011-09-30 | $0.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.077B | $0.183B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $103.449B | 21.74 |
| Cardinal Health (CAH) | United States | $54.083B | 20.65 |
| Becton Dickinson (BDX) | United States | $50.107B | 13.99 |
| West Pharmaceutical Services (WST) | United States | $25.477B | 42.59 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.194B | 0.00 |
| Align Technology (ALGN) | United States | $10.775B | 16.66 |
| Cooper (COO) | United States | $10.384B | 11.85 |
| Henry Schein (HSIC) | United States | $9.670B | 16.34 |
| Merit Medical Systems (MMSI) | United States | $5.143B | 23.47 |
| DENTSPLY SIRONA (XRAY) | United States | $2.021B | 7.09 |
| CONMED (CNMD) | United States | $1.409B | 9.84 |
| STAAR Surgical (STAA) | United States | $1.124B | 35.02 |
| Pro-Dex (PDEX) | United States | $0.230B | 21.45 |